Grimaldi, Luigi Maria Edoardo
 Distribuzione geografica
Continente #
AS - Asia 3.038
NA - Nord America 2.471
SA - Sud America 1.260
EU - Europa 306
AF - Africa 170
OC - Oceania 4
Totale 7.249
Nazione #
US - Stati Uniti d'America 2.313
SG - Singapore 1.196
BR - Brasile 950
CN - Cina 570
HK - Hong Kong 304
VN - Vietnam 258
IN - India 113
MX - Messico 100
BD - Bangladesh 98
AR - Argentina 91
IQ - Iraq 84
CO - Colombia 69
IT - Italia 65
ID - Indonesia 55
TR - Turchia 53
PK - Pakistan 50
ZA - Sudafrica 50
EC - Ecuador 49
SA - Arabia Saudita 44
VE - Venezuela 39
GB - Regno Unito 36
RU - Federazione Russa 36
FR - Francia 35
PH - Filippine 34
UZ - Uzbekistan 32
DE - Germania 31
MA - Marocco 25
CL - Cile 23
UA - Ucraina 21
CA - Canada 19
TN - Tunisia 18
KE - Kenya 17
MY - Malesia 17
AE - Emirati Arabi Uniti 14
JO - Giordania 14
PY - Paraguay 14
NP - Nepal 13
PE - Perù 13
EG - Egitto 12
ES - Italia 12
ET - Etiopia 11
NL - Olanda 11
TH - Thailandia 11
AL - Albania 10
JM - Giamaica 8
OM - Oman 8
AZ - Azerbaigian 7
BO - Bolivia 7
CR - Costa Rica 7
DZ - Algeria 6
JP - Giappone 6
LB - Libano 6
PS - Palestinian Territory 6
RS - Serbia 6
HU - Ungheria 5
IL - Israele 5
MU - Mauritius 5
BG - Bulgaria 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
IE - Irlanda 4
KW - Kuwait 4
KZ - Kazakistan 4
PA - Panama 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
AU - Australia 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
FI - Finlandia 3
LY - Libia 3
PL - Polonia 3
QA - Qatar 3
RE - Reunion 3
SN - Senegal 3
SV - El Salvador 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
DK - Danimarca 2
GE - Georgia 2
HN - Honduras 2
IR - Iran 2
KH - Cambogia 2
LK - Sri Lanka 2
NO - Norvegia 2
PT - Portogallo 2
SE - Svezia 2
TJ - Tagikistan 2
UG - Uganda 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
BE - Belgio 1
BS - Bahamas 1
CD - Congo 1
CG - Congo 1
CH - Svizzera 1
Totale 7.221
Città #
San Jose 1.428
Singapore 575
Ashburn 534
Hong Kong 296
Beijing 292
Ho Chi Minh City 96
Mexico City 77
São Paulo 70
Hanoi 48
New York 39
Rio de Janeiro 39
Santa Clara 35
Baghdad 33
Tashkent 29
Rome 22
Quito 20
Curitiba 19
Istanbul 19
Medellín 19
Brasília 18
Haiphong 17
Lahore 17
Cape Town 16
Belo Horizonte 15
Bogotá 15
Caracas 15
Dhaka 15
Porto Alegre 15
Guayaquil 14
Nairobi 14
Campinas 13
Council Bluffs 13
Guarulhos 13
Da Nang 12
Recife 12
Riyadh 12
Jeddah 11
Frankfurt am Main 10
Goiânia 10
Addis Ababa 9
Dallas 9
Jakarta 9
Johannesburg 9
Lima 9
Nova Iguaçu 9
Salvador 9
Santiago 9
Amman 8
Asunción 8
Biên Hòa 8
Casablanca 8
Caxias do Sul 8
Dammam 8
Manaus 8
Pune 8
Delhi 7
Hải Dương 7
Karachi 7
Milan 7
Secaucus 7
Baku 6
Durban 6
Kathmandu 6
Kingston 6
Kuala Lumpur 6
Maricá 6
Medina 6
Montreal 6
Mumbai 6
Muscat 6
Ourinhos 6
Rabat 6
Ribeirão Preto 6
São José dos Campos 6
Toledo 6
Valencia 6
Basra 5
Bexley 5
Buenos Aires 5
Cairo 5
Can Tho 5
Coro 5
Dubai 5
Duhok 5
Duque de Caxias 5
Fortaleza 5
Gujranwala 5
Ipatinga 5
Krasnodar 5
Los Angeles 5
Pasig-bo 5
Passo Fundo 5
Pasto 5
Quezon City 5
Santa Maria 5
Santo André 5
Surat 5
Volta Redonda 5
Atibaia 4
Bandung 4
Totale 4.352
Nome #
Cytokines and immunity in multiple sclerosis: The dual signal hypothesis 178
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy 57
Rivastigmine may be helpful for the dementia of Parkinson's disease 47
Induction of IL-1 receptor antagonist by interferon beta: Implication for the treatment of multiple sclerosis 37
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial 36
Absence of IgG, IgA or IgM oligoclonal bands in tears from multiple sclerosis patients 34
18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification 34
A novel missense mutation (L219F) in exon 8 of the preselinin 1 gene in an Italian family with presenile familial Alzheimer's disease 34
Radiomics Analysis of Brain [18 F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis 33
An Italian programme for COVID-19 infection in multiple sclerosis 33
γ Interferon activates a previously undescribed Ca2+ influx in T lymphocytes from patients with multiple sclerosis 33
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study) 32
Multiple Sclerosis Progression and Relapse Activity in Children 32
Association study of two APOE polymorphisms in Italian MS patients 31
Light chain composition of CSF and sera oligoclonal IgG bands in asymptomatic HIV seropositive (AHS) and AIDS patients with central nervous system (CNS) involvement 31
Association of early onset Alzheimer's disease with an interleukin-1 α polymorphism 30
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 30
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension 30
The Italian multiple sclerosis register 30
HTLV-I-associated myelopathy: Oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody 29
Absence of engraftment of lymphoid organs in hu-PBL SCID mice: a study employing fluorescent in situ hybridization (FISH) for the identification of human cells 29
Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with alzheimers disease: A prospective, observational study 29
Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register 29
Vigabatrin improves rigidity in Stiff-person syndrome (SPS) 29
The pervasiveness of interleukin-1 in Alzheimer pathogenesis: A role for specific polymorphisms in disease risk 29
A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis 29
Assessment of brain core temperature using MR DWI-thermometry in Alzheimer disease patients compared to healthy subjects 29
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 29
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study 29
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial 29
The role of IL-1 gene cluster in longevity: A study in Italian population 29
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 28
A polymorphism in the interleukin-1α gene influences the clinical features of migraine 28
Discontinuous distribution of IgG oligoclonal bands in cerebrospinal fluid from multiple sclerosis patients 28
A γ-interferon-activated Ca2+ influx in T-lymphocytes from multiple sclerosis patients influences immune activation during disease exacerbation 28
Intracellular Ca2+ stores of T lymphocytes: Changes induced by in vitro and in vivo activation 28
Catene leggere kappa e lambda e α-TNF in pazienti con infezione da HIV 28
Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1α 28
Longitudinal changes in social functioning in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II) 28
Anti-inflammatory and cognitive effects of interferon-?1a (IFN?1a) in a rat model of Alzheimer's disease 28
Il contributo della genetica alla prognosi delle malattie neurologiche 28
Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis 28
Cholesterol abnormalities in a cohort of Sicilian patients with multiple sclerosis 28
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population 28
Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: Relation to insulin-dependent diabetes mellitus and islet cell antibodies 28
The italian pharmacovigilance program: An observational study of adverse effects of natalizumab in multiple sclerosis therapy 28
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 28
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 28
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification 27
Interferon-β treatment does not induce a “protective” shift towards T helper 2 cells in multiple sclerosis patients 27
Search for candidate genes in common migraine in the Italian population 27
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 27
Failure to transfer multiple sclerosis into SCID mice by intraperitoneal injection of PBLs from MS patients 27
Variation of oligoclonal IgG banding pattern during lumbar CSF removal from MS patients 27
Improved conditions for the analysis of large variable number of tandemly repeated (VNTR) unit polymorphisms 27
Natalizumab in pediatric multiple sclerosis: Results of a cohort of 55 cases 27
The fate of human peripheral blood lymphocytes after transplantation into SCID mice 27
Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study 27
Immunità e flogosi nella malattia di Alzheimer 27
Relevance of an intronic polymorphism in myasthenia gravis: a preliminary study 27
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 27
Incidence of multiple sclerosis in the province of Catania. A geo-epidemiological study 26
A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects 26
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 26
Absence of central nervous system pathology in severe combined immunodeficiency mice intraperitoneally injected with peripheral blood lymphocytes from multiple sclerosis patients 26
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 26
γ-interferon activates a new Ca2+ influx in T-lymphocytes from multiple sclerosis patients 26
The molecular anatomy of human Hps60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential patogenetic role of anti-chaperonin immunity in myasthenia gravis 26
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 26
Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients 26
A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease 26
A polymorphism of the prion protein is moderately associated with age at onset and rate of cognitive impairment in Alzheimer's disease 26
Stiff-man syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome 26
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study 26
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: Report from the Italian Multiple Sclerosis Study group 26
Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination 26
Detection of anti-acetylcholine receptor antibody by an ELISA using human receptor from a rhabdomyosarcoma cell line 26
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study 26
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study 26
Analysis of an IFN-γ gene (IFNG) polymorphism in multiple sclerosis in Europe: Effect of population structure on association with disease 25
Safety and efficacy of natalizumab in children with multiple sclerosis 25
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective 25
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 25
Natalizumab in the pediatric MS population: Results of the Italian registry 25
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study 25
The immunopathology of epilepsy | Basi immunopatologiche dell'epilessia 25
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study 25
Efficacy of vitamin D 3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, doubble-blind, randomized, placebo-controlled trial 25
An isoelectric focusing study in herpes simplex virus encephalitis 25
Oligoclonal bands in the cerebrospinal fluid of post-poliomyelitis muscular atrophy ( Reply To Lassman H and to Dalakas M) 25
Analysis of cerebrospinal fluid IgA and IgG in patients with the Guillain-Barré syndrome | Analisi delle IgA e delle IgG liquorali in pazienti con sindrome di Guillain-Barré 25
Vettori erpetici per la terapia genica di patologie del sistema nervoso centrale 24
Cultures of peripheral lymphocytes of multiple sclerosis patients. Isoelectrophoretic analysis after stimulation with pokeweed mitogen | Colture di linfociti periferici di pazienti con sclerosi multipla. Analisi isoelettroforetica dopo stimolazione con pokeweed mytogen 24
INTERFERON CALCIUM PATIENTS CLINICAL ACTIVE LESIONS ON MRI (IFN)-y-INDUCED INTRACELLULAR T LYMPHOCYTES FROM PATIENTS WITH MULTIPLE SCLEROSIS PRECEDES CLINICAL EXACERBATION AND DETECTION OF ACTIVE LESIONS ON MRI 24
IL-1 receptor antagonist: a possible marker of interferon-beta1b therapeutic effectiveness in MS? 24
Reply 24
The interleukin 1-β exonic (+3953) polymorphism does not alter in vitro protein secretion 24
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: A randomised, controlled phase 3 trial 24
A chimeric human/mouse model for studying myasthenia gravis 24
The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome in patients 24
Totale 2.961
Categoria #
all - tutte 27.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.694 0 0 0 0 0 0 54 151 135 163 530 661
2025/20265.902 354 48 404 561 734 450 689 347 1.674 641 0 0
Totale 7.596